Skip to main content
BTC / USDT———ETH / USDT———SOL / USDT———BNB / USDT———XRP / USDT———DOGE / USDT———TON / USDT———AVAX / USDT———LINK / USDT———ADA / USDT———TRX / USDT———DOT / USDT———BTC / USDT———ETH / USDT———SOL / USDT———BNB / USDT———XRP / USDT———DOGE / USDT———TON / USDT———AVAX / USDT———LINK / USDT———ADA / USDT———TRX / USDT———DOT / USDT———
Visualize
Charts12 chart types: candlestick, Renko, P&F, deltaIndicators123 built-in, Barometer, no marketplaceDrawing tools82 tools: Fibonacci, Gann, Elliott, harmonicsPatterns59 candle, 19 chart and 9 harmonic patterns, auto-detected
Screen & automate
ScannerMulti-timeframe screening, 140 rulesStrategyBacktest with slippage and commissions, 40 presetsAuto-tradingWebhook, signal, DCA and grid bots
Build & practice
Any Script Converter6 languages, one clickPaper trading$10K virtual account, zero riskModules9 professional analysis modules
Open the terminal Multi-pane chart workspace. No install, free paper account.
How TW coins worksEarn TW coins for lessons, ideas, broker reviews and a daily habitLeaderboardWeekly traders ranking, resets every MondayLearn tradingLessons, quizzes and rewards TW coinsTW coinA loyalty score inside the product: earned for lessons, ideas and a daily habit. TW Coins are not money and cannot be bought, transferred or withdrawn.
Best BrokersCompare regulated forex, crypto, and stock brokers based on TW Score, regulatory status, and trader reviews.Brokers NewsCompany announcements and press releasesFind my brokerAnswer a few questions and see the brokersCompare brokersPick up to 4 brokers and compare themTrading calculatorsWork out pip value, position size and marginBroker regulatorsFinancial regulators grouped by grade and jurisdiction, and the brokers licensed by each
DocsConcepts and referenceIdeasLatest from the communityJournalLongreads, analytical articlesResearchMethod breakdowns on historical chartsProduct UpdatesNew features, releases and platform updatesWeb3 toolsLaunch and manage tokens without code
Pricing
Get started→
macroJun 25, 2026, 10:47 AM

Eli Lilly Announces Medicare GLP-1 Bridge Program for Obesity Meds

Eli Lilly will offer its obesity drugs Zepbound and Mounjaro to eligible Medicare Part D patients starting July 1, 2026, at $50/month. An estimated 20 million beneficiaries may qualify for coverage through the end of 2027.

LLY

Eli Lilly (LLY) has introduced a Medicare GLP-1 Bridge Program that will allow eligible Medicare Part D patients to access the company's obesity medicines from July 1, 2026 through December 31, 2027. The program is expected to make Zepbound or Mounjaro available at $50 per month.

According to Eli Lilly, approximately 20 million Medicare patients may qualify for obesity medicine coverage under this initiative. This represents a significant expansion of access to GLP-1 therapies for the Medicare population.

Source: First Squawk